tiprankstipranks
Trending News
More News >
Ambac Financial Group (AMBC)
:AMBC

Ambac Financial (AMBC) AI Stock Analysis

Compare
147 Followers

Top Page

AM

Ambac Financial

(NYSE:AMBC)

Rating:47Neutral
Price Target:
$6.50
▼(-8.19%Downside)
Ambac Financial's overall stock score is primarily impacted by substantial financial challenges, weak technical indicators, and a high valuation. Despite some positive aspects from the earnings call, such as growth in specific segments, the overall sentiment remains cautious due to significant net losses and operational difficulties.

Ambac Financial (AMBC) vs. SPDR S&P 500 ETF (SPY)

Ambac Financial Business Overview & Revenue Model

Company DescriptionAmbac Financial Group, Inc. (AMBC) is a financial services holding company headquartered in New York City. It primarily operates through its subsidiaries, offering financial guarantees and related services. The company's core products include bond insurance, which involves guaranteeing the payment of principal and interest on municipal and structured finance obligations. Ambac is a key player in the financial guarantee industry, serving clients across various sectors including public finance, infrastructure, and asset-backed securities.
How the Company Makes MoneyAmbac Financial Group generates revenue primarily through the premiums it charges for providing financial guarantees on bonds and structured financial products. The company earns these premiums by underwriting insurance policies that protect bondholders against defaults on the underlying obligations. In addition to premium income, Ambac also earns investment income from its investment portfolio, which includes fixed-income securities. The company's earnings are influenced by factors such as interest rates, credit risk, and the overall economic environment. Significant partnerships or collaborations with financial institutions and government entities can also impact Ambac's revenue streams by expanding its market reach and diversifying its risk exposure.

Ambac Financial Earnings Call Summary

Earnings Call Date:May 12, 2025
(Q1-2025)
|
% Change Since: -15.21%|
Next Earnings Date:Aug 11, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted strong revenue and premium growth, especially in the Insurance Distribution and Specialty Program segment, along with improved loss ratios. However, these positives were counterbalanced by a significant net loss from continuing operations, a decline in Everspan premiums, and an increased expense ratio, leading to an overall balanced sentiment.
Q1-2025 Updates
Positive Updates
Strong Start for Insurance Distribution and Specialty Program
The business produced $318 million of premium, up 70%, and generated $63 million of revenue, up 27% from the prior year, largely due to the Beat acquisition.
Significant Growth in Cirrata
Cirrata generated over $230 million of premium for the quarter, up 156%, driven by a strong pipeline of startup MGAs.
Improved Loss Ratio for Everspan
Everspan's loss ratio improved by nearly 9% or 880 basis points, indicating better underwriting management.
Cirrata Revenue Surge
Cirrata revenue increased by 129% to $41 million compared to the first quarter of 2024.
Negative Updates
Net Loss from Continuing Operations
Ambac generated a net loss from continuing operations to shareholders of $16 million, compared to a loss of $4 million in the first quarter of 2024.
Everspan Premium Decline
Everspan's gross premiums written were approximately $87 million, down 10% from the prior year.
Increased Expense Ratio for Everspan
Everspan's expense ratio increased to 35.2%, driven by lower earned premium base and no benefit from sliding scale commissions.
Operating Loss in Adjusted EBITDA
Adjusted EBITDA from continuing operations to stockholders was a loss of $1 million compared to a slight profit in the first quarter of 2024.
Company Guidance
In the first quarter of 2025, Ambac Financial Group reported significant growth in its Insurance Distribution and Specialty Program business, with $318 million in premium, marking a 70% increase, and $63 million in revenue, up 27% from the previous year. The Beat acquisition contributed notably, generating over $20 million in revenue, a 40% increase from the first quarter of 2024. Cirrata, a segment of Ambac, produced over $230 million in premium, up 156%, buoyed by the launch of six new MGAs in 2024. Despite a 2% contraction in organic growth due to strategic pullbacks in ESL and short-term medical lines, the exclusion of these lines would have resulted in nearly 12% organic growth. If Beat's performance were included, consolidated organic growth would have reached approximately 17%. Additionally, Everspan's gross premiums written were $87 million, down 10% from the previous year, yet the loss ratio improved by nearly 9%, indicating better underwriting efficiency. The overall guidance suggests strategic focus areas such as enhancing risk capacity, product diversification, and distribution expansion, all aimed at supporting future growth and profitability.

Ambac Financial Financial Statement Overview

Summary
Ambac Financial is experiencing substantial financial challenges, including significant net losses, declining revenues, and weakened cash flow. While the elimination of debt is positive, the low equity ratio and poor cash flow metrics highlight vulnerabilities.
Income Statement
30
Negative
Ambac Financial's income statement reveals significant challenges. The company experienced a dramatic net loss in 2024, with a negative net profit margin of -235.9%, down from a modest profit in 2023. Revenue growth has been erratic, with a decrease of 12.3% in 2024 following a decline from 2022 to 2023. The absence of EBIT and EBITDA in 2024 further highlights operational difficulties.
Balance Sheet
45
Neutral
The balance sheet shows a decrease in stockholders' equity, reducing from $1.36 billion in 2023 to $379 million in 2024, indicating a weakened equity position. However, the company has removed its debt obligations, improving its debt-to-equity ratio from high levels in previous years. Despite this, the equity ratio is relatively low at 6.1%, suggesting potential financial instability.
Cash Flow
35
Negative
Cash flow analysis shows a sharp decline in operating cash flow from $200 million in 2023 to $762,000 in 2024, illustrating cash generation issues. The free cash flow has also deteriorated, reflected in a negligible free cash flow growth rate. The operating cash flow to net income ratio is unfavorable, reflecting poor cash conversion efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue196.57M235.81M269.00M424.00M250.00M156.00M
Gross Profit171.87M235.81M269.00M424.00M250.00M156.00M
EBITDA-42.31M-30.52M107.00M742.00M246.00M-160.00M
Net Income-622.84M-556.45M4.00M521.00M-16.00M-437.00M
Balance Sheet
Total Assets8.25B8.06B8.43B7.97B12.30B13.22B
Cash, Cash Equivalents and Short-Term Investments213.23M8.32M28.00M1.93B1.85B2.83B
Total Debt150.00M150.00M3.48B3.75B6.45B7.23B
Total Liabilities7.04B6.86B7.00B6.65B11.19B12.07B
Stockholders Equity852.22M856.91M1.36B1.25B1.04B1.08B
Cash Flow
Free Cash Flow-27.85M762.00K200.00M1.33B-131.00M-353.00M
Operating Cash Flow-27.85M762.00K200.00M1.33B-131.00M-175.00M
Investing Cash Flow-217.37M-166.37M435.00M866.00M776.00M432.00M
Financing Cash Flow241.22M194.22M-423.00M-2.16B-657.00M-303.00M

Ambac Financial Technical Analysis

Technical Analysis Sentiment
Negative
Last Price7.08
Price Trends
50DMA
7.53
Negative
100DMA
8.49
Negative
200DMA
10.14
Negative
Market Momentum
MACD
-0.20
Negative
RSI
46.50
Neutral
STOCH
77.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMBC, the sentiment is Negative. The current price of 7.08 is below the 20-day moving average (MA) of 7.17, below the 50-day MA of 7.53, and below the 200-day MA of 10.14, indicating a bearish trend. The MACD of -0.20 indicates Negative momentum. The RSI at 46.50 is Neutral, neither overbought nor oversold. The STOCH value of 77.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMBC.

Ambac Financial Risk Analysis

Ambac Financial disclosed 53 risk factors in its most recent earnings report. Ambac Financial reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ambac Financial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (67)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
MTMTG
79
Outperform
$6.52B9.1315.12%1.89%4.64%15.36%
79
Outperform
$6.11B8.8213.29%2.06%9.87%3.41%
RDRDN
78
Outperform
$4.79B9.0813.22%2.86%2.95%4.08%
67
Neutral
$16.51B11.239.71%3.96%11.61%-10.70%
AGAGO
66
Neutral
$4.21B10.077.90%1.58%-4.43%-45.42%
47
Neutral
$325.46M65.37-2.23%10.50%-92.02%
MBMBI
28
Underperform
$215.09M26.69%583.33%6.59%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMBC
Ambac Financial
7.08
-5.43
-43.41%
AGO
Assured Guaranty
87.55
10.55
13.70%
MBI
MBIA
4.30
-0.99
-18.71%
MTG
MGIC Investment
27.60
6.43
30.37%
RDN
Radian Group
35.88
5.59
18.45%
ESNT
Essent Group
60.53
5.93
10.86%

Ambac Financial Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Ambac Financial Amends Credit Agreement for 2025
Neutral
Jun 16, 2025

On June 10, 2025, Ambac Financial Group, Inc. amended its credit agreement originally dated August 1, 2024. The amendment extends the loan maturity date to December 31, 2025, or three months after the termination of a stock purchase agreement with American Acorn Corporation. It also requires a $10 million repayment by October 31, 2025, and a 1% duration fee on November 3, 2025. Additionally, Ambac and Cirrata Group must maintain a minimum cash balance of $30 million. This amendment impacts the company’s financial obligations and liquidity management.

The most recent analyst rating on (AMBC) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Ambac Financial stock, see the AMBC Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Ambac Financial Holds Annual Stockholders Meeting
Neutral
May 30, 2025

Ambac Financial Group, Inc. held its Annual Meeting of Stockholders on May 28, 2025, where approximately 78% of the company’s shares were represented. During the meeting, stockholders elected seven directors to serve until the 2026 annual meeting, approved executive compensation, ratified KPMG LLP as the independent accounting firm for 2025, and decided to hold annual advisory votes on executive compensation.

The most recent analyst rating on (AMBC) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Ambac Financial stock, see the AMBC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 10, 2025